170 related articles for article (PubMed ID: 32328453)
21. Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study.
Mitsuya K; Nakasu Y; Hayashi N; Deguchi S; Takahashi T; Murakami H; Naito T; Kenmotsu H; Ono A; Wakuda K; Harada H
PLoS One; 2019; 14(1):e0210074. PubMed ID: 30629621
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticles in 472 Human Cerebrospinal Fluid: Changes in Extracellular Vesicle Concentration and miR-21 Expression as a Biomarker for Leptomeningeal Metastasis.
Lee KY; Im JH; Lin W; Gwak HS; Kim JH; Yoo BC; Kim TH; Park JB; Park HJ; Kim HJ; Kwon JW; Shin SH; Yoo H; Lee C
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32987772
[TBL] [Abstract][Full Text] [Related]
23. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y
Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of miRNAs in enterovirus 71-infected cells.
Xun M; Ma CF; Du QL; Ji YH; Xu JR
Virol J; 2015 Apr; 12():56. PubMed ID: 25889836
[TBL] [Abstract][Full Text] [Related]
26. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
27. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
28. Identification of key microRNAs and their targets in exosomes of pancreatic cancer using bioinformatics analysis.
Zhao X; Ren Y; Cui N; Wang X; Cui Y
Medicine (Baltimore); 2018 Sep; 97(39):e12632. PubMed ID: 30278585
[TBL] [Abstract][Full Text] [Related]
29. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.
Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B
Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556
[TBL] [Abstract][Full Text] [Related]
30. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
32. Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease.
Cirera S; Andersen-Ranberg EU; Langkilde S; Aaquist M; Gredal H
Acta Vet Scand; 2019 Dec; 61(1):57. PubMed ID: 31796072
[TBL] [Abstract][Full Text] [Related]
33. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
34. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA Profiling and Target Genes Related to Metastasis of Salivary Adenoid Cystic Carcinoma.
Feng X; Matsuo K; Zhang T; Hu Y; Mays AC; Browne JD; Zhou X; Sullivan CA
Anticancer Res; 2017 Jul; 37(7):3473-3481. PubMed ID: 28668836
[TBL] [Abstract][Full Text] [Related]
36. miRNA expression profiling of cerebrospinal fluid in patients with aneurysmal subarachnoid hemorrhage.
Stylli SS; Adamides AA; Koldej RM; Luwor RB; Ritchie DS; Ziogas J; Kaye AH
J Neurosurg; 2017 Apr; 126(4):1131-1139. PubMed ID: 27128592
[TBL] [Abstract][Full Text] [Related]
37. Circulating tumor cell characterization of lung cancer brain metastases in the cerebrospinal fluid through single-cell transcriptome analysis.
Ruan H; Zhou Y; Shen J; Zhai Y; Xu Y; Pi L; Huang R; Chen K; Li X; Ma W; Wu Z; Deng X; Wang X; Zhang C; Guan M
Clin Transl Med; 2020 Dec; 10(8):e246. PubMed ID: 33377642
[TBL] [Abstract][Full Text] [Related]
38. Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients.
González-Vallinas M; Rodríguez-Paredes M; Albrecht M; Sticht C; Stichel D; Gutekunst J; Pitea A; Sass S; Sánchez-Rivera FJ; Lorenzo-Bermejo J; Schmitt J; De La Torre C; Warth A; Theis FJ; Müller NS; Gretz N; Muley T; Meister M; Tschaharganeh DF; Schirmacher P; Matthäus F; Breuhahn K
Mol Cancer Res; 2018 Mar; 16(3):390-402. PubMed ID: 29330288
[TBL] [Abstract][Full Text] [Related]
39. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
40. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]